Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -96,974 | -45,995 | -163,918 | -118,927 | -77,002 |
| Depreciation Amortization | -878 | -247 | 1,017 | 1,088 | 972 |
| Other Working Capital | -5,111 | -687 | 18,612 | 16,244 | 20,451 |
| Other Operating Activity | 16,510 | 6,211 | 29,084 | 21,597 | 14,060 |
| Operating Cash Flow | $-86,453 | $-40,718 | $-115,205 | $-79,998 | $-41,519 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 80,444 | 48,771 | -172,324 | -209,451 | -216,955 |
| PPE Investments | -253 | -16 | -1,656 | -1,382 | -700 |
| Investing Cash Flow | $80,191 | $48,755 | $-173,980 | $-210,833 | $-217,655 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,142 | 484 | 121,963 | 121,848 | 120,772 |
| Financing Cash Flow | $13,142 | $484 | $121,963 | $121,848 | $120,772 |
| Beginning Cash Position | 33,973 | 33,973 | 201,195 | 201,195 | 201,195 |
| End Cash Position | 40,853 | 42,494 | 33,973 | 32,212 | 62,793 |
| Net Cash Flow | $6,880 | $8,521 | $-167,222 | $-168,983 | $-138,402 |
| Free Cash Flow | |||||
| Operating Cash Flow | -86,453 | -40,718 | -115,205 | -79,998 | -41,519 |
| Capital Expenditure | -253 | -16 | -1,656 | -1,382 | -700 |
| Free Cash Flow | -86,706 | -40,734 | -116,861 | -81,380 | -42,219 |